We are live on
!
Find out more
FA
FCG Advisors Portfolio holdings
AUM
$425M
1-Year Est. Return
12.09%
This Fund
S&P 500
This Quarter
Est. Return
+1.5%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
–
AUM
$320M
AUM Growth
+$34.3M
(+12%)
Cap. Flow
+$30.2M
Cap. Flow
% of AUM
9.45%
Top 10 Holdings %
Top 10 Hldgs %
61.69%
Holding
137
New
39
Increased
55
Reduced
29
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$6.13M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$5.26M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.12M |
| 4 |
iShares Select Dividend ETF
DVY
|
+$3.01M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$14.5M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$2.02M |
| 3 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$727K |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$639K |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$361K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.37% |
| 2 | Financials | 2.74% |
| 3 | Technology | 1.81% |
| 4 | Consumer Staples | 1.8% |
| 5 | Energy | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.29B
| $203K | 0.06% |
+1,893
| New | +$201K |
|
127
CVS Health
CVS
$136B
| $200K | 0.06% |
+2,092
| New | +$208K |
|
128
KKR & Co
KKR
$92.3B
| $136K | 0.04% |
+11,015
| New | +$147K |
|
129
Nokia
NOK
$57.9B
| $96K | 0.03% |
16,855
-623
| -4% | -$3.53K |
|
|
YTEN
130
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $68K | 0.02% |
8
-4
| -33% | -$45.1K |
|
131
Oxford Square Capital
OXSQ
$165M
| $54K | 0.02% |
+10,300
| New | +$54K |
|
|
ONCT
132
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $6K | ﹤0.01% |
7
-4
| -36% | -$3.74K |
|
133
Palisade Bio
PALI
$328M
| – | – |
0
| – | – |
|
134
Lloyds Banking Group
LYG
$87.6B
| – | – |
-12,588
| Closed | -$50K |
|
135
Ovintiv
OVV
$15.9B
| – | – |
-2,580
| Closed | -$79K |
|
|
UQM
136
DELISTED
UQM Technologies, Inc.
UQM
| – | – |
-10,000
| Closed | -$6K |
|
|
AERG
137
DELISTED
APPLIED ENERGETICS, INC
AERG
| – | – |
-77,841
| Closed | -$1K |
|
Similar funds
LWS
VCP
CCM
AIM
MGAI
CPF
IA
F
FCG Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, FCG Advisors held 137 positions worth $320M, up 12% from $285M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
FCG Advisors deployed $30.2M of net new capital in Q2 2016, opening 39 new positions and adding to 55 existing holdings. Its largest new stake was iShares Select Dividend ETF: 36,532 shares worth $3.12M.
By sector, the portfolio is most concentrated in Healthcare at 9.4% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Celgene Corp, an estimated $14.5M trimmed.
- FCG Advisors's largest Q2 2016 buy was iShares Select Dividend ETF: 36,532 shares worth $3.12M.
- FCG Advisors added most to iShares S&P 500 Growth ETF in Q2 2016, an estimated $6.13M increase.
- FCG Advisors's biggest Q2 2016 reduction was Celgene Corp, cutting an estimated $14.5M.
- FCG Advisors fully exited Ovintiv in Q2 2016, selling an estimated $79K.
- FCG Advisors's ten largest holdings make up 62% of its $320M portfolio in Q2 2016.
- FCG Advisors opened 39 new positions and closed 4 in Q2 2016.
- FCG Advisors's portfolio value rose 12% quarter-over-quarter to $320M.
Based on FCG Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.